Format

Send to

Choose Destination
J Bioenerg Biomembr. 2009 Oct;41(5):433-40. doi: 10.1007/s10863-009-9247-1.

Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Author information

1
Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

Abstract

Development of effective treatments for Alzheimer's disease is complicated by the poor understanding of its pathophysiology. Recent work suggests mitochondria may play a primary role in neurodegeneration, due to alterations in mitochondria turnover and that the brain is specifically susceptible, due to high energy demand. Mitochondria are the major source of cellular energy through oxidative phosphorylation and regulate intracellular calcium levels and survival pathways. Hypoxia has been implicated in several neurodegenerative diseases including Alzheimer's disease. During hypoxic events, mitochondrial complex III produces high levels of reactive oxygen species (ROS). These ROS seem to have a primary role in the regulation of the transcription factor hypoxia inducible factor 1alpha that triggers death effectors. Here we discuss the role of mitochondria in AD putting focus on the activation of hypoxia-mediated mitochondrial pathways, which could eventually lead to cell degeneration and death.

PMID:
19830532
PMCID:
PMC4054815
DOI:
10.1007/s10863-009-9247-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center